SABATINI, Stefano
 Distribuzione geografica
Continente #
AS - Asia 5.293
NA - Nord America 4.599
EU - Europa 3.583
SA - Sud America 445
AF - Africa 56
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.993
Nazione #
US - Stati Uniti d'America 4.517
CN - Cina 2.540
SG - Singapore 1.426
IT - Italia 856
IE - Irlanda 605
HK - Hong Kong 506
UA - Ucraina 491
VN - Vietnam 431
BR - Brasile 377
SE - Svezia 375
RU - Federazione Russa 370
DE - Germania 245
FI - Finlandia 187
KR - Corea 123
GB - Regno Unito 112
BE - Belgio 70
PL - Polonia 53
TR - Turchia 49
IN - India 47
JP - Giappone 44
CA - Canada 41
FR - Francia 40
MX - Messico 31
ES - Italia 30
NL - Olanda 30
AR - Argentina 28
CH - Svizzera 25
BD - Bangladesh 22
AT - Austria 20
RO - Romania 19
CZ - Repubblica Ceca 18
ZA - Sudafrica 18
UZ - Uzbekistan 16
IQ - Iraq 15
PK - Pakistan 14
EC - Ecuador 13
MA - Marocco 11
AU - Australia 10
CL - Cile 10
ID - Indonesia 10
EG - Egitto 9
PT - Portogallo 9
LT - Lituania 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
IR - Iran 7
CI - Costa d'Avorio 5
LB - Libano 5
PY - Paraguay 5
BG - Bulgaria 4
PA - Panama 4
TN - Tunisia 4
DK - Danimarca 3
GR - Grecia 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
PE - Perù 3
CO - Colombia 2
EU - Europa 2
HU - Ungheria 2
LK - Sri Lanka 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
GF - Guiana Francese 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
NR - Nauru 1
OM - Oman 1
PH - Filippine 1
SY - Repubblica araba siriana 1
Totale 13.991
Città #
Guangzhou 2.079
Singapore 961
Chandler 774
Dublin 605
Hong Kong 496
Perugia 448
San Mateo 293
Dong Ket 276
Jacksonville 271
Ashburn 248
Boardman 201
Santa Clara 180
Medford 133
Princeton 133
Seoul 121
Beijing 112
Ann Arbor 101
Wilmington 99
Altamura 91
Los Angeles 91
Moscow 86
Andover 79
Munich 75
Brussels 70
Lawrence 70
New York 64
Ho Chi Minh City 59
Turku 50
Piscataway 49
Fremont 47
São Paulo 47
Redmond 46
Warsaw 43
Des Moines 38
Tokyo 37
Saint Petersburg 36
Hanoi 35
The Dalles 34
Brooklyn 30
Dearborn 30
Rome 28
Atlanta 25
Dallas 25
Norwalk 24
Orem 24
Chicago 23
Izmir 22
Montreal 22
Helsinki 21
Falls Church 20
West Jordan 20
Spoleto 19
Stockholm 19
Ankara 18
Houston 18
Woodbridge 18
Denver 17
Poplar 17
Seattle 17
Phoenix 16
Hefei 15
Chennai 14
London 14
Redwood City 14
Boston 13
Columbus 13
Rio de Janeiro 13
Secaucus 13
Shanghai 13
Charlotte 12
Johannesburg 12
Porto Alegre 12
San Diego 12
Amsterdam 11
Bologna 11
Mexico City 11
Vienna 11
Den Haag 10
Manchester 10
San Paolo di Civitate 10
Belo Horizonte 9
Da Nang 9
Lappeenranta 9
Nuremberg 9
Querétaro 9
San Giustino 9
Brasília 8
Melbourne 8
Olomouc 8
San Francisco 8
San Jose 8
Baghdad 7
Biên Hòa 7
Bucharest 7
Curitiba 7
Hanover 7
Ninh Bình 7
Tianjin 7
West Lafayette 7
Changsha 6
Totale 9.551
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.124
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 302
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 290
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 154
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 138
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 137
Derivati 2-fenilchinolonici come inibitori della pompa di efflusso NorA dello Staphylococcus aureus ciprofloxacin resistente 128
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 126
Alternate NF-κB-independent signaling reactivation of latent HIV-1 provirus 125
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 124
Efficient microwave assisted synthesis of metal-organic framework UiO-66: optimization and scale up 122
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 122
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 118
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 113
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 112
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 112
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 111
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 110
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 110
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 107
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 107
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 106
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 106
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 106
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 105
6-Desfluoroquinolones as promising HIV transcription inhibitors 105
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 105
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 104
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 102
Investigation of targeted pyrrolizidine alkaloids in traditional Chinese medicines and selected herbal teas sourced in Ireland using LC-ESI-MS/MS 102
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 101
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 99
A GRIND based pharmacophoric model for Factor Xa inhibitors 98
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 98
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 97
A new 6-aminoquinolone compound with anti-HCMV activity 96
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 96
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 96
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus. 95
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 95
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 95
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 94
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 94
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 92
S. aureus NorA efflux pump: the discovery of new potent inhibitors 91
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 91
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 90
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 89
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 89
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 89
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 88
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 88
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 88
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 87
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 87
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 87
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 86
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 86
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 86
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 86
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 85
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 85
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 84
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 84
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 84
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 84
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 84
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 83
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 83
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 83
Impact of conventional/non-conventional extraction methods on the untargeted phenolic profile of Moringa oleifera leaves 83
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 83
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 82
Nuovi Tiopiranopiridinil Chinoloni 81
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 81
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 80
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 79
6-desfluorochinoloni (6-DFQ): sintesi assistita da microonde di 6-amino-7-(4-oxopiridinil) e 6-amino-7-(benzo-4-oxopiridinil) chinoloni 78
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 76
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 76
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA 76
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 75
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 74
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 73
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 73
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 73
Biotinylated Tryptophan Catabolites for Target Fishing. 73
Design and Synthesis of Modified Quinolones as Antitumoral Acridones 71
Novel 1,4-Benzothiazine Derivatives as Large Conductance Ca2+-Activated Potassium Channel Openers 71
Synthesis and Evaluation of Benzothiazine Derivatives as Inhibitors of NorA Efflux Pump of Staphylococcus aureus 70
Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli 70
Novel 1,4-Benzothiazine Derivatives as large conductance Ca2+-activated potassium channel activators 69
Studi di molecular modeling per il disegno di inibitori COX-2 selettivi. 69
Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium 69
Disegno e sintesi di agenti anti-HIV a duplice attività 68
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 68
Sitesi one-pot di varie 1,4-benzotiazine tramite apertura regioselettiva del 2,2-dimetiltiirano catalizzata da Cu(II)triflato 68
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 68
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 66
Highly potent KATP channel activators. 66
Totale 11.635
Categoria #
all - tutte 56.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021816 0 0 0 0 0 94 127 10 158 44 86 297
2021/20221.250 34 195 17 71 97 12 50 364 54 33 162 161
2022/20232.236 141 340 36 212 193 236 16 130 799 13 80 40
2023/20243.109 73 145 52 20 21 26 2.303 21 133 49 121 145
2024/20252.494 40 193 105 223 272 145 258 136 440 136 353 193
2025/20262.674 341 329 222 667 732 383 0 0 0 0 0 0
Totale 14.398